Neuroprogression: the hidden mechanism of depression

@article{Ruz2018NeuroprogressionTH,
  title={Neuroprogression: the hidden mechanism of depression},
  author={Norma Labra Ru{\'i}z and Daniel Santamar{\'i}a del {\'A}ngel and Hugo Ju{\'a}rez Olgu{\'i}n and Miroslava Lindoro Silva},
  journal={Neuropsychiatric Disease and Treatment},
  year={2018},
  volume={14},
  pages={2837 - 2845}
}
For many years, depressive disorder (DD) was considered a transient and natural disease of people’s mood. Its etiology had been attributed mainly to biochemical alterations of the monoamines and their receptors. Nevertheless, its prevalence and considerable impact on the family and social environment of those afflicted by it have placed the disease as a global public health problem. Neuroprogression is the term used to describe the changes in several psychiatric conditions evidenced and… 

Figures from this paper

Neuroprogression as an Illness Trajectory in Bipolar Disorder: A Selective Review of the Current Literature
  • G. Serafini, M. Pardini, Disease Management Team On Dementia Of The Irccs Ospedale Policlinico
  • Psychology, Biology
    Brain sciences
  • 2021
TLDR
According to the most relevant findings of the present review, most of the existing neuropsychological, neuroimaging, and molecular evidence demonstrates the existence of neuroprogression, at least in a subgroup of BD patients.
BDNF Impact on Biological Markers of Depression—Role of Physical Exercise and Training
TLDR
The aim of this review was to provide information of the biological markers of depression such as monoamines, tryptophan, endocannabinoids, markers of inflammatory processes (oxidative stress and cytokines) stress and sex hormones and their relationship to BDNF.
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications
TLDR
This review takes a top-down approach to assess how changes in behavior and hippocampal-dependent circuits may be attributed to abnormalities at the molecular, structural, and synaptic level.
The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective
Major depressive disorder (MDD) is an incapacitating condition characterized by loss of interest, anhedonia and low mood, which affects almost 4% of people worldwide. With rising prevalence, it is
The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder
TLDR
Elevated IL-6 levels were observed in MDD patients andIL-6 may correlate with sleep disturbances, and correlation analysis revealed that sleep disturbances positively correlated with IL- 6.
Therapeutic Potential of Curcumin in Reversing the Depression and Associated Pseudodementia via Modulating Stress Hormone, Hippocampal Neurotransmitters, and BDNF Levels in Rats.
TLDR
It is suggested from this study that pseudodementia can be reversed unlike true dementia by controlling the factors such as depression which induce memory impairment by restoring behavioral biochemical and neurochemical changes following treatment with curcumin.
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression
Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
TLDR
This review aimed to describe the effects of CEF against multiple models of neurological illnesses, drug dependency, and withdrawal and emphasizes the possible mechanisms of neuroprotective actions ofCEF with respective neurological maladies.
Antidepressant Potential of Cinnamic Acids: Mechanisms of Action and Perspectives in Drug Development
TLDR
The present review describes studies on antidepressant activity of cinnamic acids, which are natural products found in medicinal plants and foods, and the mechanisms of action of these compounds are discussed.
...
...

References

SHOWING 1-10 OF 87 REFERENCES
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
TLDR
Current knowledge of the neuroprogressive processes that may occur in MDD is reviewed, including structural brain consequences and potential molecular mechanisms including the role of neurotransmitter systems, inflammatory, oxidative and nitrosative stress pathways, neurotrophins and regulation of neurogenesis, cortisol and the hypothalamic–pituitary–adrenal axis modulation.
[Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].
TLDR
It is proposed that antidepressants influence neuroplasticity inducing improvements in the symptoms of this illness, and the effects of antidepressants on nervous, immune and endocrine systems are able to induce neuroadaptative changes in the brain.
The neurobiology of depression.
TLDR
Prospective studies examining the interaction between changes in brain function and structure in relation to stress and identified relevant genes and how these may be influenced by antidepressant drug treatment and the long-term course of depression would help clarify their role in the pathophysiology of this disorder.
Neuroprogression and Immune Activation in Major Depressive Disorder.
TLDR
Changes in disease markers involved in the reorganization of the nervous system in MDD suggest an imbalance in the immune system with increased microglial activation and decreased astroglial activation, continued elevations of the MAO-A level, and, likely, the development of extracellular glutamate dysregulation.
Neurobiological correlates of illness progression in the recurrent affective disorders.
Alterations of neuroplasticity in depression: the hippocampus and beyond
Depresion y neuroplasticidad: interaccion de los sistemas nervioso, endocrino e inmune.
TLDR
It is proposed that antidepressants influence neuroplasticity inducing improvements in the symptoms of this illness, and the effects of antidepressants on nervous, immune and endocrine systems are able to induce neuroadaptative changes in the brain.
Neurochemical aspects of depression: the past and the future?
The role of aberrant neurochemical substrates in the etiology of depression and the neurochemical mechanisms of antidepressant therapies have been the subjects of many hypotheses in the last 30
Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression
TLDR
It is confirmed that chronic forms of the two major subtypes of depression are associated with different biological correlates with inflammatory and metabolic dysregulation in atypical depression and HPA-axis hyperactivity in melancholic depression.
...
...